Erasca director granted 29,888 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. director Valerie Denise Harding received a stock option grant covering 29,888 shares of Common Stock. The options have an exercise price of $16.01 per share and expire on June 26, 2036.
All 29,888 options vest on June 26, 2027, provided she remains in continuous service with the company through that date. Following this grant, she holds 29,888 derivative securities directly, reflecting a routine, compensation-related award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 29,888 | $0.00 | $0.00 |
Footnotes (1)
- F1. 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date.
Key Figures
Key Terms
Stock option (right to buy) financial
Grant, award, or other acquisition financial
Common Stock financial
continuous service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Erasca (ERAS) director Valerie Denise Harding report in this Form 4?
What is the exercise price of Valerie Denise Harding’s Erasca (ERAS) stock options?
When do Valerie Denise Harding’s Erasca (ERAS) stock options vest and expire?
Is Valerie Denise Harding’s Form 4 for Erasca (ERAS) a buy or a sale of stock?
How many Erasca (ERAS) derivative securities does Valerie Denise Harding hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.